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ABSTRACT 
To investigate within live mammalian cells the uptake and disposition of 
combretastatins, fluorescence lifetime imaging was used with two-photon excitation 
(2PE). Combretastatin A4 (CA4) and analogues are potential anticancer drugs due to 
their ability to inhibit angiogenesis.  E(trans)-combretastatins are considerably less 
active than the Z(cis)-combretastatins proposed for clinical use. However the 
E-combretastatins exhibit stronger intrinsic fluorescence with quantum yields and 
lifetimes that depend markedly on solvent polarity and viscosity. It is proposed that 
2PE in the red and near-infrared tissue window may allow in situ isomerization of E-
combretastatins to the more active Z-isomer, offering spatial and temporal control of 
drug activation and constitute a novel form of photodynamic therapy. In the present 
work we have characterised 2PE of E-CA4 and have used fluorescence lifetime 
imaging with 2PE to study uptake and intracellular disposition of E-CA4 and an 
analogue. The results show that these molecules accumulate rapidly in cells and are 
located mainly in lipidic environments such as lipid droplets. Within the droplets the 
local concentrations may be up to 2 orders of magnitude higher than that of the drug 
in the surrounding medium.  
 
Keywords:  Combretastatin, fluorescence, lifetime, multiphoton, live cell, 
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INTRODUCTION 
The combretastatin drugs are based on the combretastatin A4 molecule isolated by 
Pettit and co-workers in 1982 from the African bush willow,1 Combretum caffrum. 
The main variant, combretastatin A4 (Z-CA4) (and the water soluble pro-drug 
phosphate ester CA4P), exert anticancer activity by binding strongly to the colchicine 
site of tubulin and preventing polymerization to microtubules.2,3  In regions 
surrounding developing tumours this leads to inhibition of angiogenesis through 
interfering with vascular endothelial-cadherin signalling,3,4 depriving the tumour of 
the nutrients required for growth. In vitro cellular assays of toxicity show Z-CA4 to be 
highly effective and active at nanomolar concentrations in the cell medium.5 
 
Combretastatins are substituted stilbenes that are two to three orders of magnitude 
more active as the Z- (cis) isomers compared with the corresponding E- (trans) 
isomers.5 This difference results from the geometrical requirements and substitution 
pattern required for molecular binding at the colchicine site on the tubulin dimer. In 
room temperature solution, E-stilbenes generally have moderate fluorescence 
quantum yields and sub-nanosecond lifetimes, whereas Z-isomers are virtually non-
fluorescent. Fluorescence yields and lifetimes of E-isomers increase with solvent 
viscosity as the competing E→Z isomerization rate decreases.6 Electronic excitation 
of fluorophores using two-photon excitation (2PE) is seen as an attractive method for 
biological imaging and cellular photochemistry7 because of the transmission of near 
infrared light through tissue and readily available ultrafast Ti:sapphire lasers 
providing MHz 200 fs pulse trains. The concept of using 2PE to isomerise E-
combretastatins relates to other biological applications of multiphoton excitation such 
as in photodynamic therapy8 where tissues are very much more transparent in the 
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near-infrared region (700 – 900 nm) than in the visible spectrum.9 For fluorescence 
microscopy 2PE also has the advantage of pseudo confocality (because of the 
femtolitre volume targeted where sufficiently high photon densities are obtained 
within the focussed laser spot) and allows excitation of UV-absorbing fluorophores 
that is usually prevented by absorbing elements within the microscope optics or the 
cell itself.10 In an alternative approach to the development of combretastatins as anti-
cancer agents and as probes in identification of the cellular site of action, aryl  azide 
derivatives of Z-CA4 have been identified as excellent candidates for photoaffinity 
labeling studies of tubulin.11 
  
In this report we describe real time observation of the intracellular uptake of two 
E-combretastatins in live cells (HeLa and Chinese hamster ovary (CHO) cells) using 
fluorescence lifetime imaging (FLIM).  The compounds used were the E-isomers of 
combretastatin A4 (E-CA4) and the analogous fluorinated derivative (E-CA4F) 
(Figure 1). The validity of two photon excitation of E-combretastatins in the 
wavelength range of 560-630 nm is demonstrated by quantifying fluorescence 
lifetimes and quantum yields and comparing results with conventional one-photon 
excitation in the ultraviolet. The information obtained from within the cell using 
fluorescence intensity images is supplemented by the fluorescence lifetime images 
which, together with co-localization studies using Nile Red, indicating the subcellular 
regions into which combretastatins accumulate. Furthermore, combinations of 
intensity and lifetime images allow semi-quantitative measurements of intracellular 
combretastatin concentrations, demonstrating substantial accumulation of the 
compounds within both cells types. 
 
5 
 
MATERIALS AND METHODS 
Solvents for spectroscopy (Sigma-Aldrich or Alfa Aesar, analytical or spectroscopic 
grade) were used as supplied. Anhydrous dimethylformamide was purchased from 
Sigma-Aldrich, whilst tetrahydrofuran and diethyl ether were freshly distilled over 
sodium and benzophenone under an argon atmosphere. Nile Red, 2-aminopyridine 
(2APY) and L-tryptophan were supplied by Sigma-Aldrich and 9-chloroanthracene 
(9CLA) by Alfa Aesar.  
 
Combretastatins E-CA4 and E-CA4F were synthesized according to published 
procedures12,13 and purified by flash column chromatography on silica gel (35-70 μm 
diameter, 60 Å pore size) with petroleum ether:EtOAc 19:1 and recrystallized from 
ethanol. Identity and purity of the materials were confirmed by thin layer 
chromatography and 1H and 13C NMR spectroscopy at 400 MHz and 100 MHz 
respectively (Bruker AC-400). 
 
HeLa and Chinese hamster ovary (CHO) cells were from the European Collection of 
Cell Cultures. HeLa cells were cultured in MEM medium (Gibco) containing 10% 
foetal calf serum, penicillin (100 units/mL), streptomycin (100 µg/mL) and glutamine 
(2 mM). CHO cells were cultured in DMEM (Gibco) with the same additions as for 
the HeLa cells. For microscopy, adherent cell cultures were grown in 35 mm diameter 
glass-bottom culture dishes with optical quality glass (MatTek Corporation) and 
incubated at 37 °C in a humidified atmosphere containing 5 % CO2. 
 
Absorption spectra were measured in Perkin Elmer Lambda 25 or 950 
spectrophotometers. Fluorescence measurements were made with Spex Fluoromax or 
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Varian Cary Eclipse spectrofluorimeters using the spectral correction curves supplied 
by the manufacturers. Fluorescence quantum yields with UV (one-photon) excitation 
were determined using either 2-aminopyridine (Φref 0.6)14 or 9-chloroanthracene (Φref 
0.50 in dichloromethane, determined here relative to 9,10-diphenylanthracene in 
cyclohexane (Φref 0.97 ) and anthracene in ethanol (Φref 0.28)15 as standards. 
Fluorescence quantum yields were determined from the relative slopes of plots of 
integrated fluorescence intensity versus (1-10-A) for samples having absorbance A ≤ 
0.1. The square of the refractive index (n2) correction was applied for work in 
different solvents. Sample irradiation was minimized by use of narrow excitation slits 
to reduce photoisomerization. Repeated fluorescence scans of the sample under these 
conditions showed almost no change in fluorescence intensity. 
 
The fluorescence lifetime imaging system with multiphoton excitation has been 
described previously.16,17 The sources for multiphoton excitation were a Ti:Sapphire 
laser, tuneable 700 - 1000 nm and producing 180 fs pulses at 76 MHz, and an optical 
parametric oscillator (OPO) pumped by a second Ti:Sapphire laser. With the doubled 
idler output of the OPO, useful energies (>200 mW) could be obtained between 550 
and 640 nm. Samples were excited on the stage of a Nikon TE2000U inverted 
microscope using a water immersion x60 objective of NA 1.2. Fluorescence was 
measured with either a spectrometer (Acton 275) and CCD setup (Andor iDUS), 
enabling emission spectra and intensities to be determined, or with a time-correlated 
single photon counting (TCSPC) system (Becker and Hickl SPC-830 and software) 
enabling fluorescence lifetime measurements and fluorescence lifetime imaging 
(FLIM). For the E-combretastatin lifetimes measured in solution, data was collected 
to 104 counts in the peak channel and good fits to a single exponential decay were 
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obtained using the Becker and Hickl software with typical values of χ2 ≤ 1.4.  For 
FLIM fluorescence was isolated by combined narrowband interference (400IU25) and 
BG3 (Comar) filters. The sample could also be imaged using a confocal imaging 
system (Nikon eC1-Si) on the same microscope using 488 and 543 nm excitation. Cell 
images were overlaid using Adobe Photoshop CS3. 2PE cross sections were 
determined as described by Mathai et al.,18 using 9-chloroanthracene as a reference 
fluorophore.19  
 
RESULTS AND DISCUSSION 
1. Fluorescence properties – spectra, quantum yields and fluorescence lifetimes 
The absorption and fluorescence emission spectra of E-CA4 and E-CA4F in 
dichloromethane are similar (Figure 2) with E-CA4 and E-CA4F having ultraviolet 
absorption maxima at 332 and 329 nm respectively. In contrast, Z-CA4 has a less 
intense absorption maximum at shorter wavelength (298 nm). The fluorescence 
quantum yields (φ) for E-combretastatins with UV excitation (290-300 nm) were 
found to strongly depend on solvent polarity and viscosity, ranging from 0.07 to 0.42 
with lower values in low viscosity, polar protic solvents (methanol and ethanol) and 
higher values in non-polar or viscous polar solvents (hexane and glycerol). 
Fluorescence quantum yields for E-CA4F were generally higher than for E-CA4.  
 
Fluorescence lifetimes were determined using 2PE at 630 nm with the microscope 
TCSPC setup (overall time response of 25 ps fwhm) and produced the results shown 
in Table 1. All the fluorescence decays were fitted well by a single exponential. The 
fluorescence lifetime of E-CA4 exhibited a strong solvent dependence, ranging from 
230 ps in a polar solvents such as methanol to 860 ps in hexane. In the very viscous 
8 
 
environment provided by glycerol the lifetime increases further to 1180 ps. In the 
range of alkanols studied the lifetime is closely correlated with solvent viscosity as 
shown in the inset to Figure 3. The data from all solvents investigated indicates that 
fluorescence lifetime is a complex function of solvent properties including polarity 
and viscosity. However it is clear that the measured lifetime has the potential to report 
on cellular environments in FLIM studies. For E-CA4F similar trends are observed, 
but the overall differences in both lifetimes and quantum yields over the range of 
solvents are rather less than for E-CA4. The fluorescence lifetimes of E-CA4F are 
confined to a narrower range having values ranging from 440 ps in methanol through 
750 ps in hexane to 1070 ps in glycerol. The more pronounced solvent dependence for 
E-CA4 reflects the more polar nature of the molecule compared with E-CA4F. The 
relative solute polarities may be judged from the partition coefficients (P) calculated 
according to the method of Brown et al..20 Log P values of for E-CA4 and E-CA4F 
are 3.81 and 4.62 respectively, confirming E-CA4F to be the more lipophilic of the 
two compounds. A plot of fluorescence quantum yields versus fluorescence lifetimes 
for both E-CA4 and E-CA4F is shown in Figure 3. The results show the anticipated 
linear relation21 between quantum yield (Φ) and lifetime (τ) in the form  
Φ/Φο = τ/το     .....(1)  
Furthermore both compounds behave similarly indicating a similar natural lifetime 
(τo). This is a very useful result for FLIM studies described below since even though 
the intracellular fluorophore lifetime may vary between (and within) the imaged 
sample and a calibrating fluorophore solution, the observed intracellular intensities 
may be adjusted by the use of the lifetime image through equation (1) to obtain 
quantitative estimates of the intracellular fluorophore concentration. 
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Compared with the commonly used fluorescent labels and probes with absorption and 
emission maxima in the visible spectral region and with quantum yields approaching 
unity, these properties of E-CA4 and E-CA4F are considerably less favourable for 
imaging with fluorescence microscopy. Nonetheless it has previously been 
shown16,22,23  that it is possible to excite UV fluorescence in the region of 340-400 nm 
from intracellular 5-hyroxytryptophan, serotonin and propranolol using 2PE at 630 
nm. At this excitation wavelength background interference from intracellular 
fluorophores such as tryptophan and cofactors is minimised.24 Log-log plots of 
fluorescence intensity (I) versus laser power (P) for E-combretastatins in solution all 
demonstrated a slope of 2.0 ± 0.2, consistent with the anticipated quadratic power 
dependence for 2PE (equation (2)). 
 
I = σ2P2       ....................(2) 
 
Published cross sections for two photon absorption (σ2, the probability of an 
absorption process or photon interaction) show large variations depending on the 
method of measurement and the power range and pulse duration of the laser used for 
excitation.18 Values of σ2 were measured using a 9-chloroanthracene (9ClA) as a 
reference  fluorophore18 with an appropriate fluorescence spectrum and measured 2PE 
cross-sections.19 The values of σ2 at 620 nm for E-CA4 and E-CA4F in DCM were 
determined to be 2.1 ± 0.5 and 2.75 ± 0.6 GM units respectively. The combination of 
Ti-sapphire laser and OPO allowed investigation of decreasing wavelength to 560 nm, 
whereupon E-CA4 showed a substantial increase in cross section (Figure 2), similar to 
that reported for bis(diphenylamino)-stilbene by Makarov et al..19  
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2. Cell uptake and intracellular fluorescence of E-combretastatins 
Intracellular distributions of E-combretastatins in cell monolayers were obtained 
using fluorescence lifetime imaging, in which the rastered excitation laser beam 
dwells on each pixel for a few milliseconds and at each position records a nanosecond 
fluorescence lifetime decay curve using TCSPC. The intensity image is constructed 
from the integrated photon count, which may then be modified using the lifetime 
information. Typically the microscopic field of observation contained between 15 and 
20 live cells. Figure 4 shows fluorescence intensity images of CHO cells before and 
after incubation with either E-CA4 or E-CA4F, using 2PE at 628 nm and measuring 
fluorescence at 400 nm. The micrographs show clear images of the intracellular 
distribution of both compounds within the cells minutes after addition. Excellent 
contrast is obtained with negligible cell autofluorescence from unlabelled cells under 
the conditions used. Plots of fluorescence intensity versus incubation time (Figure 4) 
show biphasic uptake with an initial unresolved rapid phase within the first 100 
seconds and a slower phase lasting over several minutes. The initial rise in 
fluorescence in Figure 4C cannot be ascribed to the fluorescence of E-combretastatin 
added to and remaining in the extracellular medium. On the basis of the intensity from 
calibration solutions, the added E-combretastatin (10 µM) would be expected to 
contribute an additional 0.56 counts per pixel in these images, compared with an 
initial rise of 3.6 counts per pixel in Figure 4C. Furthermore, the longer (>900 ps) 
fluorescence lifetimes in the intracellular FLIM image indicate an intracellular 
viscous or hydrophobic environment for E-CA4F even at this early stage (see below).  
Both E-CA4 and E-CA4F are excluded from the cell nucleus, and E-CA4 appears to 
be located mainly within the cytoplasmic region of the cell. In contrast E-CA4F 
shows a more punctuate distribution in CHO cells. 
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Fluorescence intensity and lifetime images of E-CA4 in HeLa cells are shown in 
Figure 5A. The lifetimes range between 750 and 1200 ps, with a peak in the 
distribution at 900 ps. E-CA4F in HeLa and CHO cells has a peak in the lifetime 
distribution at 1.1 ns (Figure 5B and 5C). These intracellular fluorescence lifetimes 
are longer than in hexane (0.86 ns, Table1) but similar to that in glycerol (1.18 ns) and 
suggest that the E-combretastatins occupy a non-polar and/or viscous environment 
within the cells. The microviscosities of the hydrophobic interiors of lipid bilayer 
membranes25 and triglyceride lipid emulsion droplets26 are between approximately 0.5 
and 1 poise and similar to that of glycerol (0.95 poise at 25 ºC). Further evidence for 
the locations of E-combretastatins in these cells was obtained from labelling with Nile 
Red, a dye known to localise in lipid droplets and membrane systems in cells. 27 Nile 
Red staining of cells previously loaded with E-combretastatins was imaged using the 
confocal scanning facility on the multiphoton microscope using an excitation 
wavelength of 488 nm to preferentially observe lipid droplets over membranes.28 
Examples of Nile Red stained images are shown in comparison with fluorescence 
intensity and lifetime images in Figures 5, together with overlaid intensity/lifetime 
and Nile Red images. Figure 5C shows the results for E-CA4F uptake in CHO cells. 
The intensity images show a low background level of fluorescence intensity within 
the cell cytoplasm and intense staining in localised regions identified as lipid droplets 
by co-localisation with Nile Red fluorescence. Slight discrepancies in the co-
localization result from the use of two different imaging systems (the multiphoton 
intensity/lifetime images and the confocal image of Nile Red fluorescence). The 
higher uptake of E-CA4F into lipid droplets in CHO cells compared with that of 
E-CA4 (Figures 4 and 5) may arise from the higher hydrophobicity of E-CA4F noted 
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above. Figures 5A and 5B show uptake of E-CA4 and E-CA4F into HeLa cells. 
Compared with the CHO cells, there are fewer lipid droplets within the HeLa cells 
and the compounds are preferentially located within the cytoplasmic regions. 
 
Quantification of fluorophore concentration from intensity measurements is aided by 
the simultaneous recording of fluorescence lifetime images and the observation that 
fluorescent lifetimes for E-CA4 and E-CA4F are linearly related to quantum yield. 
Dynamic quenching of fluorescence, may be taken into account and sample 
fluorophore concentration (CS) determined quantitatively by comparison of the 
sample fluorescence intensity (IS) and lifetime (τS) with those of a standard reference 
solution (IR, τR) of known concentration (CR):- 
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A series of solutions containing increasing concentrations of E-CA4F in DMSO were 
used to produce a linear calibration curve. DMSO was chosen since it produces a 
reasonably long lifetime and is more easily handled than glycerol. Using this 
procedure, concentration maps of intracellular combretastatin were obtained and 
examples shown in Figures 6A – 6C. Initial studies with HeLa cells and E-CA4 added 
to the serum at 100 µM led to the result in Figure 6A. Substantial regions of the cell 
cytoplasm contain in excess of 2 mM E-CA4 whilst smaller regions contain in excess 
of 4 mM, or more than 20 - 40 times the concentration of E-CA4 in the medium. This 
demonstrates that the compound is rapidly taken up and concentrated within the cell, 
making it available as a drug to interfere with cell function such as microtubule 
activity. Further investigations used only 10 µM combretastatin in the medium 
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(Figures 6B and 6C). Figure 6C shows that the concentration of E-CA4F within the 
lipid droplets in CHO cells reaches peaks of almost 10 mM whilst substantial regions 
of the cells contain around 1 mM of the compound. For the less lipophilic E-CA4 
(Figure 9B6B) the peak concentrations are less but substantial regions of the cell 
cytoplasm contain between 250 and 750 µM of the drug. This indicates a 
concentrating of the drug by a factor of 25-75 times that in the surrounding medium. 
 
CONCLUSIONS 
Overall these results show that the E-combretastatins are rapidly (within minutes) 
accumulated by live mammalian cells and reach intracellular concentrations many 
times those in the medium. This is likely to be a passive process depending mainly on 
the lipophilicity of these compounds. In typical toxicity assays the concentrations of 
Z- and E-combretastatin A4 required to kill these cells are determined to be in the 
nanomolar and micromolar regions respectively.5 The present results suggest that the 
true intracellular concentrations are much higher and for Z-CA4 may correspond more 
closely to the micromolar concentrations at which inhibition of microtubule assembly 
is observed.29 Since the active Z-combretastatins exhibit extremely weak 
fluorescence, only with the less active but more fluorescent E-combretastatins has it 
been possible here to observe the rapid intracellular accumulation. Since the E- and Z-
isomers are likely to differ very little in terms of lipophilicity, it may be expected that 
Z-combretastatins are similarly accumulated within mammalian cells. 
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Table 1 Fluorescence lifetimes (in ns) and quantum yields for combretastatin 
fluorescence in a range of solvents at 20 ºC.  The lifetimes were 
measured using two-photon excitation (620-630 nm). The fluorescence 
quantum yields were obtained with 290-300 nm excitation with 
2-aminopyridine in H2SO4 (0.2 mol dm-3) as the fluorescence standard 
(φ 0.60). The quantum yields are estimated to be ± 10%. Fluorescence 
decays were all good exponentials with estimated lifetimes ± 5%. 
 
 
 
 
  
τ φ τ φ
MeOH 0.23 0.071 0.44 0.15
EtOH 0.28 0.093 0.48 0.17
Ethylene glycol 0.58 0.19 0.76 0.29
Glycerol 1.18 0.35 1.07 0.42
MeCN 0.29 0.099 0.59 0.2
DCM 0.50 0.19 0.61 0.23
DMSO 0.49 0.15 0.81 0.29
Hexane 0.86 0.36 0.75 0.31
E- CA4 E- CA4F
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FIGURE LEGENDS 
 
Figure 1 Structures of E- and Z-combretastatin A4 and fluorinated analogue 
used in this study. 
 
Figure 2 Normalised one-photon absorption and fluorescence spectra of the 
E-CA4 (full curves) and E-CA4F (dotted curves). The spectrum of 
Z-CA4F (dashed curved) is shown for comparison with the absorbance 
at the correct ratio to that of E-CA4F. Also shown are the 2-photon 
cross sections for E-CA4 (-) on a wavelength scale (top axis) at 
twice that used for the one-photon spectra. All spectra were measured 
in dichloromethane. 
 
Figure 3 Correlation between fluorescence quantum yield and fluorescence 
lifetime (both measured at 20 ºC) for E-CA4 () and E-CA4F () in 
the range of solvents shown in Table 1. Inset: Effect of solvent 
viscosity on fluorescence lifetimes and quantum yields for the alkanols 
in Table 1.  
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Figure 4 Fluorescence images of CHO cells before (images A1 and B1) and at 
30 seconds (A2, B2), 3 minutes (A3, B3) and 6 minutes (A4, B4) after 
addition of E-CA4F (series A) or E-CA4 (series B) at 22 ºC. Both 
combretastatins were added to a final concentration of 10 µmol dm-3. 
Fluorescence at 400 nm was excited by two-photon absorption at 628 
nm. Panel C shows the overall average number of counts per pixel (•) 
and maximum (peak) pixel intensity within the image () after 
addition of E-CA4F (series A). 
 
Figure 5 Fluorescence lifetime imaging of E-CA4 and E-CA4F in cells and co-
localization with Nile Red. A: E-CA4 (100 µmol dm-3 in medium) with 
HeLa cells; cells; B:  E-CA4F (50 µmol dm-3 in medium) with HeLa 
cells; C: E-CA4F (50 µmol dm-3 in medium) with CHO. Frames show 
(a) intensity images of combretastatin fluorescence at 400 nm with 628 
nm 2-photon excitation, (b) Nile Red fluorescence (515 – 535 nm) 
excited at 488 nm, and  (c) fluorescence lifetime images. Below are (d) 
the overlaid images of the drug and Nile Red images (a and b) and (e) 
the fluorescence lifetime distributions derived from the lifetime 
images. The bar represents 20 µm. 
 
Figure 6 Contour plots showing intracellular concentrations of combretastatins 
in cells at room temperature after incubation for approximately 10 
minutes: A: E-CA4 (100 µM added) in HeLa cells; B: E-CA4 (10 µM 
added) in CHO cells (the image corresponds to that in Figure 8A4A); 
C: E-CA4F (10 µM added) in CHO cells. The concentrations are 
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calculated using the intensity and lifetime at each pixel as described in 
the text. Each plot represents an area of 70 x70 µm. The vertical scales 
show the combretastatin concentration in µM. 
